Galapagos’ CEO makes donation of €10 million in the form of personal shares to African Parks
December 23 2020 - 12:00PM
Galapagos’ CEO makes donation of €10 million in the form of
personal shares to African Parks
Mechelen, Belgium; 23 December 2020, 18.00
CET – Galapagos NV (Euronext & NASDAQ: GLPG) today
announces that Onno van de Stolpe, CEO of Galapagos, has committed
to make a personal €10 million donation to African Parks, a
non-profit organization that serves at the front lines of wildlife
conservation, ecosystem restoration, and community development. The
€10 million donation will be in the form of ordinary shares of
Galapagos, donated by Mr. van de Stolpe to African Parks and spread
over the coming five years. The first €2 million (25,150 ordinary
shares held by Mr. van de Stolpe) have been transferred on 22
December 2020.
“I strongly believe that we all have a
responsibility to make this world a better place.” said Onno van de
Stolpe: “For me, African Parks is a very worthy cause to contribute
to in order to make this happen. Saving the African nature reserves
for future generations, with their animals, flora and in harmony
with the local populations, is providing hope in a world that
urgently needs it.”
“We are extremely grateful to Onno in making
this very generous commitment to African Parks, where our vision is
to make the parks under our management ecologically, socially and
financially sustainable,” said Peter Fearnhead, CEO of African
Parks. “A gift like this one is just so important for building the
longterm financial base necessary to sustain the portfolio of 19
parks spanning 14.5m hectares. And the timing is essential in that
protecting nature now is more important than ever, and inextricably
linked to the health of our planet and our very own survival.”
About African ParksAfrican
Parks is a non-profit conservation organisation that takes on the
complete responsibility for the rehabilitation and long-term
management of national parks in partnership with governments and
local communities. We currently manage 19 national parks and
protected areas in 11 countries covering 14.5 million hectares in:
Angola, Benin, Central African Republic, Chad, the Democratic
Republic of Congo, Malawi, Mozambique, the Republic of Congo,
Rwanda, Zambia and Zimbabwe. For more information
visit www.africanparks.org, Twitter, Instagram and Facebook.
About GalapagosGalapagos NV
discovers and develops small molecule medicines with novel modes of
action, several of which show promising patient results and are
currently in late-stage development in multiple diseases. Our
pipeline comprises discovery through Phase 3 programs in
inflammation, fibrosis and other indications. Our ambition is to
become a leading global biopharmaceutical company focused on the
discovery, development and commercialization of innovative
medicines. More information at www.glpg.com.
Contacts
Investors:Elizabeth GoodwinVP Investor
Relations +1 781 460 1784
Sofie Van GijselSenior Director Investor Relations+32 485 19 14
15ir@glpg.com
Media:Carmen VroonenGlobal Head of
Communications & Public Affairs+32 473 824 874
Anna GibbinsSenior Director Therapeutic Areas Communications+44
7717 801900communications@glpg.com
- Galapagos’ CEO makes donation of €10 million in the form of
personal shares
Galapagos (EU:GLPG)
Historical Stock Chart
From Sep 2024 to Oct 2024
Galapagos (EU:GLPG)
Historical Stock Chart
From Oct 2023 to Oct 2024